L

Laboratorios Farmaceuticos Rovi
ROVI

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€2.85B
EV
€2.94B
Shares Outstanding
51.15M
Beta
0.45

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€79.08
P/E 2025E
21.88x
P/Revenue 2025E
3.92x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Laboratorios Farmaceuticos Rovi, S.A.

gainify

L

Laboratorios Farmaceuticos Rovi, S.A.

ROVI

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitami...

Sector

Healthcare

Industry

Biotechnology

CEO

Lopez-Belmonte Encina, Juan

Employees

2,197

IPO Date

2007-12-05

Headquarters

Calle JosE Isbert, 2, Pozuelo de AlarcOn, Madrid, Madrid, 28223, Spain

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.